Author

S. M. Rubin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Research Focus:cell signaling & trafficking· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:gene regulatory network inference· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1

Frequent Co-Authors

A. N. Iness· 1 shared B. R. Topacio· 1 shared C. S. Tambo· 1 shared E. T. Wick· 1 shared E. Zatulovskiy· 1 shared J. E. Purvis· 1 shared J. Felthousen· 1 shared J. M. Skotheim· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. N. Iness

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2

T. P. Enrico, W. Stallaert, E. T. Wick, P. Ngoi, S. M. Rubin, N. G. Brown, J. E. Purvis, M. J. Emanuele

This study identifies cyclin F as a regulator of p130/RBL2 degradation via SCF, showing its role in cell cycle control and potential implications in cancer.

bioRxiv · Apr 23, 2021Cell Biology

The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb

A. N. Iness, J. Felthousen, V. Ananthapadmanabhan, K. Z. Guiley, M. Dozmorov, S. M. Rubin, L. Litovchick

This study shows that B-Myb disrupts the DREAM complex by affecting LIN52 protein levels and DYRK1A kinase activity, contributing to cancer progression.

Oncogene · Sep 11, 2018Peer-reviewedCancer Biology

Cyclin D-Cdk4,6 drives cell cycle progression via the retinoblastoma protein’s C-terminal helix

B. R. Topacio, E. Zatulovskiy, S. Cristea, S. Xie, C. S. Tambo, S. M. Rubin, J. Sage, M. Koivomägi, J. M. Skotheim

This study shows cyclin D-Cdk4,6 drives cell cycle progression by phosphorylating Rb's C-terminal helix, which is distinct from other cyclin-Cdk interactions and critical for tumor suppression.

bioRxiv · Aug 21, 2018Cell Biology